COVID-19 ICU patients may face higher superbug risk

NCT ID NCT04378842

Completed Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examined whether being in the ICU with COVID-19 made patients more likely to pick up dangerous, drug-resistant bacteria. Researchers tracked 368 critically ill adults to compare infection rates before and during the pandemic. The goal was to understand if COVID-19 changed the spread of these superbugs in ICUs, which can help hospitals improve safety measures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 Critical Illness Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS SARS-COV2

Contacts and locations

Show contact details

Locations

CH LENS

Lens, France
Ch Bethune

Béthune, France
Chu Amiens Picardie

Amiens, France
Grand Hopital de L'Est Francilien

Jossigny, France
Hospices Civils de Lyon

Lyon, France
Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)

Lyon, France
Hôpital Roger Salengro, ICU, CHU Lille

Lille, 59037, France